New Zealand model of OTC sildenafil earns praise

A small study has investigated community pharmacist attitudes to the over-the-counter (OTC) supply of sildenafil in New Zealand, finding it has enhanced their primary...

Environmentally responsible inhaled respiratory treatments – Implications for practice

Ziqi is a regular at your pharmacy. She has popped in today to purchase a salbutamol pressurised metered dose inhaler (pMDI). You notice on her dispensing history that this will be her third in the last 4 weeks and she is overdue to have her repeat for her budesonide dry powder inhaler (DPI) filled.

Medication management in older Australians

A national pharmacy-led working group dedicated to improving the quality use of medicines for older Australians has issued 10 recommendations for better integrating healthcare...

Industry pharmacist, technology expert

It took a trip to Canada, but Danielle Bancroft MPS went from community pharmacist to Product Manager and User Experience (UX) Designer at Fred...

The therapeutic potential of psychedelics

Thom, 37, a regular patient of the pharmacy, presents their venlafaxine repeat for dispensing. You know this has been prescribed for PTSD and ask how they have been going with their treatment. They disclose that their symptoms have been difficult to manage over the last few weeks and that they don’t feel like their medication has been working as well. Thom explains that a friend mentioned MDMA could be used for PTSD, and they’re now considering taking it to help them feel better.

Weighing up the options

A flood of weight loss injectables is on its way, which may aid pharmacists in helping to stem the obesity crisis.